For Doctors in a Hurry
- Researchers investigated how primary cilia dysfunction, specifically mutations in the CEP41 gene, contributes to the development of autism spectrum disorders.
- The study utilized human cortical organoids carrying the CEP41 R242H point mutation to model early brain development and cellular signaling.
- Mutant organoids exhibited shorter cilia and reduced tubulin polyglutamylation, a modification that stabilizes the ciliary structure and regulates intracellular signaling.
- The researchers concluded that CEP41 mutations disrupt interneuron development and increase upper layer cortical neuron formation, altering cellular differentiation.
- These cellular changes likely cause an excitation and inhibition imbalance, a physiological state frequently associated with the clinical presentation of autism.
Ciliary Dysfunction and the Architecture of Neurodevelopmental Disorders
The clinical heterogeneity of autism spectrum disorder is mirrored by a complex genetic landscape involving more than 100 risk genes that influence early brain assembly [1, 2]. Transcriptomic analyses of human induced pluripotent stem cells (adult cells reprogrammed to an embryonic-like state) indicate that diverse genetic insults often converge on shared pathways governing the proliferation of neural progenitors and the maturation of synaptic circuits [3, 1]. For instance, mutations in the amino acid transporter SLC7A5 disrupt the balance of large neutral amino acids, which are essential nutrients for protein synthesis, leading to altered lipid metabolism and stage-specific shifts in neuronal activity patterns [4]. Similarly, homozygous mutations in the CNTNAP2 gene have been shown to drive increased neural progenitor proliferation and significant brain overgrowth in forebrain organoid models [5]. While primary cilia (sensory organelles on the cell surface) are known regulators of signaling, a recent study investigating the CEP41 R242H mutation demonstrates how shortened cilia and reduced tubulin polyglutamylation (a post-translational modification affecting microtubule stability) impair the differentiation of both excitatory and inhibitory neurons [6]. These cellular imbalances likely contribute to the excitation and inhibition dysregulation frequently observed in clinical autism presentations [6, 7].
Structural Defects in the R242H Ciliary Model
To investigate the mechanisms by which genetic variations influence neurodevelopment, researchers utilized human cortical organoids (three-dimensional brain tissue models derived from stem cells that mimic the early stages of corticogenesis). The study focused on the CEP41 gene, which encodes a centrosomal protein located at the basal body (the anchoring structure of the cilium) and the ciliary axoneme (the microtubule-based core of the organelle). Mutations in CEP41 are clinically significant because they are found in individuals with autism spectrum disorder and Joubert syndrome, a ciliopathy characterized by cerebellar malformations and a high incidence of autism. Specifically, the team characterized the impact of the CEP41 R242H point mutation, a variant identified in clinical cases of autism, to determine how it alters the structural integrity of primary cilia. Primary cilia serve as essential sensory hubs that control cell-to-cell signaling during brain assembly. The researchers found that while the R242H mutation did not interfere with the correct ciliary localization of the CEP41 protein, it induced profound structural abnormalities. Cilia carrying the R242H mutation were significantly shorter than those in control organoids, a physical defect that compromises their ability to receive and process extracellular signals. Further biochemical analysis revealed that these mutant cilia exhibited lower levels of tubulin polyglutamylation, a specific post-translational modification that stabilizes microtubules within the axoneme. This reduction in polyglutamylation is a critical finding, as it serves as a direct indicator of altered cilia stability and impaired signaling capacity. For clinicians, these structural deficits offer a cellular explanation for the developmental disruptions observed in patients with ciliopathies, linking microscopic organelle dysfunction to macroscopic neurodevelopmental delays.
Transcriptional Shifts and Interneuron Maturation
To investigate the molecular consequences of ciliary dysfunction, the researchers performed single-cell RNA sequencing (a high-resolution technique that measures gene expression in thousands of individual cells simultaneously) on the mutant organoids. This analysis focused on the downstream effects of the CEP41 R242H mutation, which is highly relevant to the etiology of Joubert syndrome and its associated autism phenotypes. The sequencing data revealed that the expression of several transcription factors with critical roles in interneuron development was altered in mutant interneurons. These transcription factors are specialized proteins that bind to specific DNA sequences to regulate the rate of gene transcription, essentially acting as the master switches for cellular identity. The study found that these transcriptional disruptions were not limited to mature cells; rather, the expression of transcription factors was also altered in the progenitors of mutant interneurons, which are the precursor cells responsible for generating the brain's inhibitory signaling network. By disrupting the genetic program of these progenitors, the CEP41 mutation fundamentally shifts the trajectory of interneuron maturation. These genetic alterations have direct implications for the structural composition of the developing cortex. Beyond the defects in inhibitory cell lines, the CEP41 mutation also caused an augmented formation of upper layer cortical neurons, which are primarily excitatory in nature. This simultaneous disruption of interneuron development and the overproduction of excitatory neurons suggests a specific cellular mechanism for the excitation and inhibition imbalance that is widely recognized as a convergent mechanism underlying neurodevelopmental disorders. For the practicing physician, these findings provide a clear biological link between the primary cilia defects seen in Joubert syndrome and the broader neurobiological patterns associated with autism spectrum disorder.
Implications for the Cortical Excitation and Inhibition Balance
The researchers observed that the CEP41 R242H mutation significantly impacted the cellular architecture of the cortical organoids by altering the production of specific cell types. Specifically, the CEP41 mutation caused an augmented formation of upper layer cortical neurons, which are the glutamatergic cells responsible for excitatory communication within the brain. This finding demonstrates that CEP41 controls the differentiation of both excitatory and inhibitory neurons, acting as a critical regulator of the lineage decisions that determine a cell's final identity. By influencing the rate at which progenitor cells become specific types of neurons, the mutation shifts the expected ratios of cell populations during the peak periods of cortical assembly. The clinical significance of these cellular shifts lies in the resulting physiological state of the developing brain. The study suggests that alterations in CEP41-mediated differentiation may lead to an excitation and inhibition imbalance, a state where the ratio of excitatory glutamatergic signaling to inhibitory GABAergic signaling is pathologically skewed. This excitation and inhibition imbalance is recognized as a convergent mechanism underlying neurodevelopmental disorders, including autism spectrum disorder and the cognitive symptoms associated with Joubert syndrome. For the clinician, these data provide a biological framework for understanding how a single point mutation in a ciliary protein can disrupt the global network stability of the cortex. Ultimately, recognizing this cellular etiology may help guide future diagnostic strategies and targeted interventions for patients presenting with complex neurodevelopmental phenotypes linked to primary cilia dysfunction.
References
1. Gordon A, Yoon S, Bicks LK, et al. Developmental convergence and divergence in human stem cell models of autism.. Nature. 2026. doi:10.1038/s41586-025-10047-5
2. Gordon A, Yoon S, Bicks L, et al. Developmental convergence and divergence in human stem cell models of autism spectrum disorder. bioRxiv. 2024. doi:10.1101/2024.04.01.587492
3. Niu W, Yu S, Li X, et al. Longitudinal multi-omics reveals pathogenic TSC2 variants disrupt developmental trajectories of human cortical organoids derived from Tuberous Sclerosis Complex. bioRxiv. 2024. doi:10.1101/2024.10.07.617121
4. Knaus LS, Basilico B, Malzl D, et al. Large neutral amino acid levels tune perinatal neuronal excitability and survival. Cell. 2023. doi:10.1016/j.cell.2023.02.037
5. Jong JOD, Llapashtica C, Genestine M, et al. Cortical overgrowth in a preclinical forebrain organoid model of CNTNAP2-associated autism spectrum disorder. Nature Communications. 2021. doi:10.1038/s41467-021-24358-4
6. Hasenpusch‐Theil K, Lesayova A, Kozić Z, et al. ASD mutations in the ciliary gene CEP41 impact development of projection neurons and interneurons in a human cortical organoid model. bioRxiv. 2025. doi:10.1101/2025.07.09.663904
7. Pigoni M, Uzquiano A, Paulsen B, et al. Cell-type specific defects in PTEN-mutant cortical organoids converge on abnormal circuit activity.. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddad107
